Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-09-014019
Filing Date
2009-06-04
Accepted
2009-06-04 17:09:12
Documents
1
Period of Report
2009-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4499
  Complete submission text file 0001140361-09-014019.txt   6598
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-227
Business Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-227 650-470-4500
Inverlochy Consultadoria & Servicos L.D.A. (Reporting) CIK: 0001384386 (see all company filings)

State of Incorp.: S1 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 09874800